[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100589902":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":26,"centralContacts":30,"locations":21,"responsibleParty":36,"collaborators":21,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":21,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":21,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":21,"overallStatus":58,"whyStopped":21,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":21},{"fullName":5,"class":6},"Geisinger Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Receiving treatment with both laser types","EXPERIMENTAL","Participants will receive split-body treatment, receiving Nd:YAG laser treatment to an affected anatomical site (axilla, inframammary region, or groin) and Alexandrite laser to the contralateral side. The treatment side will be randomized and maintained through the study.",[13,14],"Device: Nd:YAG Laser","Device: Alexandrite Laser",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DEVICE","Nd:YAG Laser","Nd:YAG laser applied to one side of the participant's body (e.g. left or right) according to randomization, every 4-6 weeks for 4 consecutive treatments.",[9],null,{"type":17,"name":23,"description":24,"armGroupLabels":25,"otherNames":21},"Alexandrite Laser","Alexandrite laser applied to the contralateral side of the participant's body (e.g. left or right) according to randomization, every 4-6 weeks for 4 consecutive treatments.",[9],[27],{"name":28,"affiliation":5,"role":29},"Mikael K Horissian, MD","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":21,"email":35},"Saritha Research Project Manager","CONTACT","570-214-3453","skorukonda1@geisinger.edu",{"type":29,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"Mickey Horissian","Assistant Professor of Dermatology","100589902","ndyag-vs-alexandrite-laser-treatment-in-hidradenitis-suppurativa-100589902",false,"NCT06960447","Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa","Comparative Efficacy of Nd:YAG and Alexandrite Laser Treatments in Hidradenitis Suppurativa: A Split-Person, Non-Inferiority Study","Inclusion Criteria:\n\n* Geisinger male or female patients with a diagnosis of hidradenitis suppurativa (all stages of disease)\n* 12-75 years of age\n* Not on concurrent systemic therapy (e.g., antibiotics, biologic therapies)\n* Must have not used systemic therapies within 2 weeks of enrollment in study\n* Able and willing to provide consent\n\nExclusion Criteria:\n\n* Patients who cannot tolerate laser therapy\n* Patients who cannot wear protective eyewear\n* Patients who are pregnant","ALL","12 Years","75 Years",{"count":50,"type":51},21,"ESTIMATED","INTERVENTIONAL",[54],"NA","The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).",[57],"Hidradenitis Suppurativa (HS)","NOT_YET_RECRUITING","2026-04-24",{"date":61,"type":62},"2026-04-28","ACTUAL",{"date":64,"type":51},"2026-07",{"date":66,"type":51},"2027-07",{"name":5,"class":6}]